Abstract
The magnetic resonance imaging (MRI)-less non-standard pipeline for amyloid positron emission tomography (PET) published by Bourgeat et al., in 2018 calculates Centiloid scale values that are highly consistent with those computed using the standard pipeline. The purpose of this study was to demonstrate that the non-standard pipeline can compute Centiloid scale values in high agreement with the standard pipeline when using different datasets of amyloid PET tracers in our local computer environment. PET images of (11)C-Pittsburgh compound B ((11)C-PiB), (18)F-florbetapir, (18)F-flutemetamol, (18)F-florbetaben, and (18)F-NAV4694 from the calibration dataset were processed using both the standard and non-standard pipelines, and the computed cortical standardized uptake value ratio (SUVr) value was converted to the Centiloid scale value using the method described by Klunk et al., in 2015. The conversion equations from the SUVr to Centiloid scale values for each tracer were obtained during this process. Using these equations, we compared the Centiloid scale values obtained using the standard and non-standard pipelines using the validation datasets of each tracer from the Japanese Alzheimer's Disease Neuroimaging Initiative (J-ADNI), Alzheimer's Disease Neuroimaging Initiative (ADNI), and Australian Imaging Biomarkers and Lifestyle (AIBL). In the calibration datasets, there was high agreement (R(2) > 0.97) and slight bias between the Centiloid scale values calculated by the non-standard and standard pipelines for all tracers. Despite relatively little NAV4694 data in the validation datasets, there was high agreement between the Centiloid scale values calculated using the non-standard and standard pipelines for all tracers. The bias for florbetaben and NAV4694 using the non-standard pipeline was 1.6% underestimation and 3.3% overestimation, respectively; these values were smaller than those reported by Bourgeat et al. Analysis of outliers also suggested that the non-standard pipeline might be vulnerable to anatomical anomalies. Given the slight variance of the Centiloid scale in young controls, flutemetamol and NAV4694 might be suitable tracers for the non-standard pipelines. This study demonstrates the replicability of the non-standard pipelines across computing environments, datasets, scanners, and tracers. When MRI is not available, the non-standard pipeline may provide information to aid in visual assessment of amyloid PET.